Market Cap 147.32M
Revenue (ttm) 490,000.00
Net Income (ttm) -51.42M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -10,493.88%
Debt to Equity Ratio 0.00
Volume 1,201,800
Avg Vol 654,296
Day's Range N/A - N/A
Shares Out 39.50M
Stochastic %K 52%
Beta 0.56
Analysts Strong Sell
Price Target $13.00

Company Profile

Vistagen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders. The company's product pipeline includes Fasedienol, an investigational pherine nasal spray that is in Phase III clinical trial for the treatment of anxiety in adults with social anxiety disorder; and Itruvone, an odorless synthetic investigational neuroactive pherine nasal spray, which is in Phase II clinical trial...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 577 3600
Address:
343 Allerton Avenue, South San Francisco, United States
Iightning
Iightning Dec. 5 at 6:45 AM
1ightning® Premium Options Alert (Actionable) Ticker: $VTGN Contract: Dec 19 $5C Entry: 1.02 Exit: 1.75 Return: +70.52% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
BioBum
BioBum Dec. 5 at 12:57 AM
$VTGN This administration LOVES raving about reducing controlled substances/illegal drugs. FDA is just waiting for vistagen to semi-succeed. I think they receive very favorable judgement with the FDA , as long as they can just give them at least moderate success. FDA won’t care about the one failed trial. Even if we get 2 out of 4, I think they still have hope 😂
1 · Reply
Heroforest
Heroforest Dec. 5 at 12:49 AM
$VTGN I am wondering how much an one trial is enough from FDA impact VTGN. Technically they can just submit palsade 2 data ?
0 · Reply
Iightning
Iightning Dec. 5 at 12:34 AM
1ightning® Premium Options Alert (Actionable) Ticker: $VTGN Contract: Dec 19 $5C Entry: 1.02 Exit: 1.75 Return: +70.52% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
AverageTraders
AverageTraders Dec. 4 at 11:37 PM
What is happening to ticker SNSE now?! Looks like they are going to SQUEEZE ticker SNSE up next .. SNSE is breaking out like crazy.. Its insane what's going on in this market.. Looks like all eyes are going to SNSE now.. $GNS $PSKY $VTGN $OCGN nxe
1 · Reply
marketCaptain
marketCaptain Dec. 4 at 11:24 PM
$VTGN Fakeout to The downside through two long term trend channels to perfectly revisit The yearly vwap, to Then slice through The vwap standard deviation like butter in one day. Technically The chart screams new highs while we wait for the readout
2 · Reply
To_De_Moon
To_De_Moon Dec. 4 at 10:31 PM
$VTGN Gemini says this: Vistagen will most likely release the data between the second and third week of December (December 9 to December 20, 2025). Although the company has not provided an exact date, this estimate is based on three key factors recently confirmed: Official Guidance ("By Year-End"): On November 3, 2025, Vistagen announced that the last patient had completed the study and reiterated that "top-line" results would be published before the end of the year. This leaves December as the only possible window. Data Analysis Timeline: Typically, a biotech company takes between 4 and 6 weeks from the last patient visit (Nov 3) to "database lock" and the publication of results. 4 weeks: Would lead to early December (where we are now). 6 weeks: Would lead to the week of December 15. Avoiding Holidays: Companies usually avoid releasing critical data during Christmas week (week of the 22nd) or between Christmas and New Year's, as trading volume is low and the news might lose impact.
0 · Reply
DarkApp33
DarkApp33 Dec. 4 at 9:42 PM
$VTGN What. A. Week.
0 · Reply
AvengerTrader
AvengerTrader Dec. 4 at 9:18 PM
What is happening to ticker SNSE now?! Looks like they are going to SQUEEZE ticker SNSE up next .. SNSE is breaking out like crazy.. Its insane what's going on in this market.. Looks like all eyes are going to SNSE now.. Watching: $PSKY $VTGN $OCGN $ARBK as well
0 · Reply
MakesHerSquirt
MakesHerSquirt Dec. 4 at 8:58 PM
$VTGN Is this where I can get some of that FASEDIENOL ! !! LFG !!!
1 · Reply
Latest News on VTGN
Vistagen Appoints Nick Tressler as Chief Financial Officer

Dec 1, 2025, 8:30 AM EST - 3 days ago

Vistagen Appoints Nick Tressler as Chief Financial Officer


Vistagen to Participate in Stifel Healthcare Conference 2025

Nov 5, 2025, 8:30 AM EST - 4 weeks ago

Vistagen to Participate in Stifel Healthcare Conference 2025


Vistagen Appoints Paul Edick to its Board of Directors

Oct 29, 2025, 8:30 AM EDT - 5 weeks ago

Vistagen Appoints Paul Edick to its Board of Directors


Vistagen (VTGN) Q1 R&D Expense Jumps 54%

Aug 7, 2025, 11:59 PM EDT - 4 months ago

Vistagen (VTGN) Q1 R&D Expense Jumps 54%


Vistagen to Present at the BTIG Virtual Biotechnology Conference

Jul 24, 2025, 8:30 AM EDT - 4 months ago

Vistagen to Present at the BTIG Virtual Biotechnology Conference


Vistagen to Participate in Stifel 2025 Virtual CNS Forum

Mar 4, 2025, 8:30 AM EST - 9 months ago

Vistagen to Participate in Stifel 2025 Virtual CNS Forum


Vistagen to Present at the Stifel 2024 Healthcare Conference

Nov 14, 2024, 8:30 AM EST - 1 year ago

Vistagen to Present at the Stifel 2024 Healthcare Conference


Iightning
Iightning Dec. 5 at 6:45 AM
1ightning® Premium Options Alert (Actionable) Ticker: $VTGN Contract: Dec 19 $5C Entry: 1.02 Exit: 1.75 Return: +70.52% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
BioBum
BioBum Dec. 5 at 12:57 AM
$VTGN This administration LOVES raving about reducing controlled substances/illegal drugs. FDA is just waiting for vistagen to semi-succeed. I think they receive very favorable judgement with the FDA , as long as they can just give them at least moderate success. FDA won’t care about the one failed trial. Even if we get 2 out of 4, I think they still have hope 😂
1 · Reply
Heroforest
Heroforest Dec. 5 at 12:49 AM
$VTGN I am wondering how much an one trial is enough from FDA impact VTGN. Technically they can just submit palsade 2 data ?
0 · Reply
Iightning
Iightning Dec. 5 at 12:34 AM
1ightning® Premium Options Alert (Actionable) Ticker: $VTGN Contract: Dec 19 $5C Entry: 1.02 Exit: 1.75 Return: +70.52% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
AverageTraders
AverageTraders Dec. 4 at 11:37 PM
What is happening to ticker SNSE now?! Looks like they are going to SQUEEZE ticker SNSE up next .. SNSE is breaking out like crazy.. Its insane what's going on in this market.. Looks like all eyes are going to SNSE now.. $GNS $PSKY $VTGN $OCGN nxe
1 · Reply
marketCaptain
marketCaptain Dec. 4 at 11:24 PM
$VTGN Fakeout to The downside through two long term trend channels to perfectly revisit The yearly vwap, to Then slice through The vwap standard deviation like butter in one day. Technically The chart screams new highs while we wait for the readout
2 · Reply
To_De_Moon
To_De_Moon Dec. 4 at 10:31 PM
$VTGN Gemini says this: Vistagen will most likely release the data between the second and third week of December (December 9 to December 20, 2025). Although the company has not provided an exact date, this estimate is based on three key factors recently confirmed: Official Guidance ("By Year-End"): On November 3, 2025, Vistagen announced that the last patient had completed the study and reiterated that "top-line" results would be published before the end of the year. This leaves December as the only possible window. Data Analysis Timeline: Typically, a biotech company takes between 4 and 6 weeks from the last patient visit (Nov 3) to "database lock" and the publication of results. 4 weeks: Would lead to early December (where we are now). 6 weeks: Would lead to the week of December 15. Avoiding Holidays: Companies usually avoid releasing critical data during Christmas week (week of the 22nd) or between Christmas and New Year's, as trading volume is low and the news might lose impact.
0 · Reply
DarkApp33
DarkApp33 Dec. 4 at 9:42 PM
$VTGN What. A. Week.
0 · Reply
AvengerTrader
AvengerTrader Dec. 4 at 9:18 PM
What is happening to ticker SNSE now?! Looks like they are going to SQUEEZE ticker SNSE up next .. SNSE is breaking out like crazy.. Its insane what's going on in this market.. Looks like all eyes are going to SNSE now.. Watching: $PSKY $VTGN $OCGN $ARBK as well
0 · Reply
MakesHerSquirt
MakesHerSquirt Dec. 4 at 8:58 PM
$VTGN Is this where I can get some of that FASEDIENOL ! !! LFG !!!
1 · Reply
mb0157
mb0157 Dec. 4 at 8:52 PM
$VTGN $4 calls in high demand!!
1 · Reply
Haimalon
Haimalon Dec. 4 at 8:40 PM
$VTGN This new CFO owes me a lot of money 😊
0 · Reply
BioBum
BioBum Dec. 4 at 8:29 PM
$VTGN can you not combine two trials and get a combined p value? Again, I’m not a stats guy. And ChatGPT give me a different combined p value all the time lol
1 · Reply
BioBum
BioBum Dec. 4 at 7:28 PM
$VTGN I asked ChatGPT if you combine pal 1 with pal 2, do you get statistically significant results and it says yes with a p value of 0.045. I’m not a huge stats guy Is this true? Crazy if accurate
5 · Reply
BlindLemonBoosh
BlindLemonBoosh Dec. 4 at 6:46 PM
$VTGN was selling then. Averaged back in from 4.13 to 3.39. Waiting...
1 · Reply
StoinkMaestro
StoinkMaestro Dec. 4 at 5:15 PM
$VTGN bounced as expected
0 · Reply
Jsanders77
Jsanders77 Dec. 4 at 4:53 PM
$VTGN oh my dear bears today.....
0 · Reply
RemoteInvestor
RemoteInvestor Dec. 4 at 4:44 PM
$VTGN Yes, I did! Hopefully the last time below $4.00
0 · Reply
marketCaptain
marketCaptain Dec. 4 at 4:33 PM
$VTGN might be the last time this stock reached sub 4
1 · Reply
kimgysen
kimgysen Dec. 4 at 4:01 PM
0 · Reply
Stockrunner54
Stockrunner54 Dec. 4 at 3:39 PM
$VTGN final positions everyone. It’s almost time for the show !
0 · Reply
MoffaMan
MoffaMan Dec. 4 at 2:54 PM
$VTGN how many purchased this trash last week when it was over $5 ? Lol
1 · Reply